Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
- PMID: 22161841
- DOI: 10.1387/ijdb.113371dl
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Abstract
Macrophages display remarkable plasticity, allowing these cells to adapt to changing microenvironments and perform functions as diverse as tissue development and homeostasis, inflammation, pathogen clearance and wound healing. Macrophage activation can be triggered by Th1 cytokines and pathogen-associated or endogenous danger signals, leading to the formation of classically activated or M1 macrophages. On the other hand, anti-inflammatory mediators, including IL-4, IL-10, TGF-β and M-CSF, induce diverse anti-inflammatory types of macrophages, known under the generic term M2. In human breast carcinomas, tumor-associated macrophage (TAM) density correlates with poor prognosis. In mouse models of breast cancer, eliminating macrophages from the tumor site, either via genetic or therapeutic means, results in retarded tumor progression. Over the years, multiple signals from the mammary tumor microenvironment have been reported to influence the TAM phenotype and TAM have been propagated as anti-inflammatory M2-like cells. Recent developments point to the existence of at least two distinct TAM subpopulations in mammary tumors, based on a differential expression of markers such as CD206 or MHC II and different in vivo behaviour: perivascular, migratory TAM which are less M2-like, and sessile TAM found at tumor-stroma borders and/or hypoxic regions that resemble more M2-like or "trophic" macrophages. Hence, a further refinement of the molecular and functional heterogeneity of TAM is an avenue for further research, with a potential impact on the usefulness of these cells as therapeutic targets.
Similar articles
-
[Human mammary carcinoma. A model for the relationship between tumor proliferation, tumor-associate macrophages, and prognostic factors].Veroff Pathol. 1992;138:1-235. Veroff Pathol. 1992. PMID: 1323168 Review. German.
-
COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps.Carcinogenesis. 2011 Sep;32(9):1333-9. doi: 10.1093/carcin/bgr128. Epub 2011 Jul 5. Carcinogenesis. 2011. PMID: 21730361
-
Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.Int J Oncol. 2011 May;38(5):1409-19. doi: 10.3892/ijo.2011.960. Epub 2011 Mar 3. Int J Oncol. 2011. PMID: 21373754
-
Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.J Immunol. 2011 Feb 15;186(4):2192-200. doi: 10.4049/jimmunol.1000475. Epub 2011 Jan 14. J Immunol. 2011. PMID: 21239715
-
Inflammation and cancer: breast cancer as a prototype.Breast. 2007 Dec;16 Suppl 2:S27-33. doi: 10.1016/j.breast.2007.07.013. Epub 2007 Aug 30. Breast. 2007. PMID: 17764938 Review.
Cited by
-
Engineered endosymbionts that alter mammalian cell surface marker, cytokine and chemokine expression.Commun Biol. 2022 Aug 30;5(1):888. doi: 10.1038/s42003-022-03851-6. Commun Biol. 2022. PMID: 36042261 Free PMC article.
-
The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.Front Immunol. 2021 Apr 13;12:654877. doi: 10.3389/fimmu.2021.654877. eCollection 2021. Front Immunol. 2021. PMID: 33927723 Free PMC article. Review.
-
Endotoxin Triggers Tumor Initiation Events in Nontumorigenic Breast Epithelial Cells and Enhances Invasion-Related Phenotype in Pretumorigenic and Tumorigenic Breast Epithelial Cells.Int J Inflam. 2021 Nov 26;2021:4666380. doi: 10.1155/2021/4666380. eCollection 2021. Int J Inflam. 2021. PMID: 34868543 Free PMC article.
-
mTOR at the Transmitting and Receiving Ends in Tumor Immunity.Front Immunol. 2018 Mar 27;9:578. doi: 10.3389/fimmu.2018.00578. eCollection 2018. Front Immunol. 2018. PMID: 29662490 Free PMC article. Review.
-
Tumor-associated macrophages: from mechanisms to therapy.Immunity. 2014 Jul 17;41(1):49-61. doi: 10.1016/j.immuni.2014.06.010. Immunity. 2014. PMID: 25035953 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials